Back
Armata Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
ARMP
Armata Pharmaceuticals
Last Price:
2.25
Seasonality Move:
35.12%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARMP is experiencing buying pressure, which is a positive indicator for future bullish movement.
Armata Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.31 | Sell |
| 20-day SMA: | 2.32 | Sell |
| 50-day SMA: | 2.32 | Sell |
| 200-day SMA: | 2.79 | Sell |
| 8-day EMA: | 2.24 | Buy |
| 20-day EMA: | 2.31 | Sell |
| 50-day EMA: | 2.35 | Sell |
| 200-day EMA: | 2.6 | Sell |
Armata Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 47.47 | Sell |
| Chaikin Money Flow: | 4195 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.16 - 2.5) | Sell |
| Bollinger Bands (100): | (2.2 - 2.74) | Sell |
Armata Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Armata Pharmaceuticals Stock
Is Armata Pharmaceuticals Stock a Buy?
- Armata Pharmaceuticals share price is 2.25 while ARMP 8-day simple moving average is 2.31, which is a Sell signal.
- The stock price of ARMP is 2.25 while Armata Pharmaceuticals 20-day SMA is 2.32, which makes it a Sell.
- Armata Pharmaceuticals 50-day simple moving average is 2.32 while ARMP share price is 2.25, making it a Sell technically.
- ARMP stock price is 2.25 and Armata Pharmaceuticals 200-day simple moving average is 2.79, creating a Sell signal.
ARMP Technical Analysis vs Fundamental Analysis
Buy
61
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy or a Sell?
-
Armata Pharmaceuticals stock is rated a Buy
The current Armata Pharmaceuticals [ARMP] share price is $2.25. The Score for ARMP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Armata Pharmaceuticals Stock Info
Market Cap:
81.41M
Price in USD:
2.25
Share Volume:
5.17K
Armata Pharmaceuticals 52-Week Range
52-Week High:
4.48
52-Week Low:
1.98
Buy
61
Armata Pharmaceuticals (ARMP)
is a Buy
Armata Pharmaceuticals Share Price Forecast
-
What is the Armata Pharmaceuticals stock price today?
The Armata Pharmaceuticals stock price is 2.25 USD today. -
Will ARMP stock go up or go down?
Armata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Armata Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Armata Pharmaceuticals is not overvalued.
Is Armata Pharmaceuticals Stock a Buy?
- Armata Pharmaceuticals share price is 2.25 while ARMP 8-day exponential moving average is 2.24, which is a Buy signal.
- The stock price of ARMP is 2.25 while Armata Pharmaceuticals 20-day EMA is 2.31, which makes it a Sell.
- Armata Pharmaceuticals 50-day exponential moving average is 2.35 while ARMP share price is 2.25, making it a Sell technically.
- ARMP stock price is 2.25 and Armata Pharmaceuticals 200-day simple moving average is 2.60, creating a Sell signal.
Fundamental Analysis of Armata Pharmaceuticals
Is Armata Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.
Technical Analysis of Armata Pharmaceuticals
Should I short Armata Pharmaceuticals stock?
- ARMP Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Armata Pharmaceuticals is a Sell
- Armata Pharmaceuticals Relative Strength Index (RSI) is 47.47, which suggest Armata Pharmaceuticals is oversold
- The Bollinger Bands (25) for Armata Pharmaceuticals is (2.16 - 2.5), which suggest Armata Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Armata Pharmaceuticals is (2.2 - 2.74), which suggest Armata Pharmaceuticals is a Sell
* Armata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.